IMARC Group, a leading market research company, has recently released a report titled “Next-Generation Sequencing (NGS) Market Report by Sequencing Type (Whole Genome Sequencing, Targeted Resequencing, Whole Exome Sequencing, RNA Sequencing, CHIP Sequencing, De Novo Sequencing, Methyl Sequencing, and Others), Product Type (Instruments, Reagents and Consumables, Software and Services), Technology (Sequencing by Synthesis, Ion Semiconductor Sequencing, Single-Molecule Real-Time Sequencing, Nanopore Sequencing, and Others), Application (Biomarker and Cancer, Drug Discovery and Personalized Medicine, Genetic Screening, Diagnostics, Agriculture and Animal Research, and Others), End-User (Academic Institutes Research Centers, Hospitals Clinics, Pharmaceutical Biotechnology Companies, and Others), and Region 2024-2032”. The study provides a detailed analysis of the industry, including the global next-generation sequencing (NGS) market share, trends, size, and industry trends forecast. The report also includes competitor and regional analysis and highlights the latest advancements in the market.
The global next generation sequencing market size reached US$ 20.1 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 80.4 Billion by 2032, exhibiting a growth rate (CAGR) of 16.2% during 2024-2032.
Request to Get the Sample Report:
https://www.imarcgroup.com/next-generation-sequencing-market/requestsample
Global Next Generation Sequencing Market
Next-generation sequencing (NGS), also known as high-throughput sequencing, is a revolutionary technology that has enabled the sequencing of millions to billions of DNA molecules simultaneously. Unlike the first-generation sequencing method, Sanger sequencing, which analyzes one DNA fragment at a time, NGS rapidly sequences large stretches of DNA or even whole genomes. Next-generation sequencing works by first breaking down the DNA into smaller fragments. These fragments are then amplified and sequenced simultaneously in a massively parallel fashion, which is generating enormous amounts of data. Bioinformatics tools are then used to piece together these sequences into a complete genomic sequence.
Global Next Generation Sequencing Market
The increasing genomic research activities to understand genetic variants linked to diseases represents one of the key factors driving the growth of the market across the globe. The ability of NGS to sequence entire genomes or targeted regions is revolutionizing genomics and molecular biology, which is propelling its demand. The market is also driven by significant advancements in NGS technology, including improvements in speed, accuracy, and the development of cost-effective miniaturized portable sequencers. The increasing funding in genomics research and government initiatives supporting the use of NGS technologies for achieving improved healthcare outcomes are fueling the growth of the market.
Apart from this, the rising emphasis on personalized medicine for providing tailored medical treatment to individual characteristics, needs, and preferences of a patient is also acting as a major growth-inducing factor. NGS helps identify genetic mutations linked to diseases and drug responses, which is further facilitating personalized treatment plans. The growing use of NGS in clinical diagnostics for the detection of various diseases like cancer, neurological disorders, and infectious diseases is creating a positive outlook for the market across the globe.
Next Generation Sequencing Market Report Segmentation:
Breakup by Sequencing Type:
- Whole Genome Sequencing
- Targeted Resequencing
- Whole Exome Sequencing
- RNA Sequencing
- CHIP Sequencing
- De Novo Sequencing
- Methyl Sequencing
- Others
Breakup by Product Type:
- Instruments
- Reagents and Consumables
- Software and Services
Breakup by Technology:
- Sequencing by Synthesis
- Ion Semiconductor Sequencing
- Single-Molecule Real-Time Sequencing
- Nanopore Sequencing
- Others
Breakup by Application:
- Biomarker and Cancer
- Drug Discovery and Personalized Medicine
- Genetic Screening
- Diagnostics
- Agriculture and Animal Research
- Others
Breakup by End-User:
- Academic Institutes Research Centers
- Hospitals Clinics
- Pharmaceutical Biotechnology Companies
- Others
Breakup by Region:
- North America
- Asia Pacific
- Europe
- Latin America
- Middle East and Africa
Competitive Landscape with Key Players:
The competitive landscape of the next-generation sequencing market size has been studied in the report with the detailed profiles of the key players operating in the market.
Some of These Key Players Include:
- Agilent Technologies
- Becton Dickinson and Company
- 10x Genomics, BGI Group
- Eurofins Scientific
- Hoffmann-La Roche AG
- Illumina Inc.
- Genewiz
- Macrogen
- Oxford Nanopore Technologies
- Pacific Biosciences
- PerkinElmer
- Thermo Fisher Scientific
- Qiagen N.V.
- GenapSys Inc.
Ask Analyst for Customized Report:
https://www.imarcgroup.com/request?type=reportid=2039flag=C
Key Highlights of the Report:
- Market Performance (2018-2023)
- Market Outlook (2024-2032)
- Market Trends
- Market Drivers and Success Factors
- Impact of COVID-19
- Value Chain Analysis
If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.
About Us
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Contact Us:
IMARC Group
134 N 4th St
Brooklyn, NY 11249, USA
Website: imarcgroup.com
Email: sales@imarcgroup.com
Americas: +1-631-791-1145 | Europe Africa: +44-753-713-2163 | Asia: +91-120-433-0800
